Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2020-09, Vol.95 (9), p.E247-E250
Hauptverfasser:	Galadanci, Najibah A., Abdullahi, Shehu U., Ali Abubakar, Shehi, Wudil Jibir, Binta, Aminu, Hauwa, Tijjani, Aliyu, Abba, Muhammad S., Tabari, Musa A., Galadanci, Aisha, Borodo, Awwal Musa, Belonwu, Raymond, Salihu, Auwal S., Rodeghier, Mark, Ghafuri, Djamila L., Covert C Greene, Brittany V., Neville, Kathleen, Kassim, Adetola A., Kirkham, Fenella J., Jordan, Lori C., Aliyu, Muktar H., DeBaun, Michael R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia, Sickle Cell - drug therapy Child Child, Preschool Female Hematology Humans Hydroxyurea Hydroxyurea - administration & dosage Hydroxyurea - adverse effects Male Nigeria Sickle cell disease Stroke - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!